Itratuf SB 50mg Capsule contains Itraconazole, a broad-spectrum triazole antifungal agent used for the treatment of various fungal infections. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. This medication is indicated for the management of systemic and superficial mycoses, including aspergillosis, blastomycosis, histoplasmosis, onychomycosis, and dermatophytosis. It is particularly effective against infections caused by Candida species and dermatophytes. Itratuf SB 50mg Capsule is administered orally and should be taken with food to enhance absorption. The dosage and duration of treatment depend on the type and severity of the infection, as well as patient-specific factors such as age, hepatic function, and concomitant medications. Common adverse effects may include gastrointestinal disturbances, headache, dizziness, and rash. Itraconazole has potential drug interactions due to its inhibition of cytochrome P450 enzymes, necessitating careful review of concomitant therapies. Caution is advised in patients with hepatic impairment or congestive heart failure. Regular monitoring of liver function tests and clinical response is recommended during prolonged therapy to ensure safety and efficacy.